[1]朱　昱.骨化三醇在桥本甲状腺炎甲状腺功能减退症患者中的应用[J].新乡医学院学报,2017,34(8):709-711.[doi:10.7683/xxyxyxb.2017.08.012]
　ZHU Yu.Application of calcitriol in Hashimoto′s thyroiditis patients with hypothyroidism[J].Journal of Xinxiang Medical University,2017,34(8):709-711.[doi:10.7683/xxyxyxb.2017.08.012]
点击复制

骨化三醇在桥本甲状腺炎甲状腺功能减退症患者中的应用
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年8
页码:
709-711
栏目:
临床研究
出版日期:
2017-08-05

文章信息/Info

Title:
Application of calcitriol in Hashimoto′s thyroiditis patients with hypothyroidism
作者:
朱　昱
（河南省永煤集团总医院外二科，河南　永城　476600）
Author(s):
ZHU Yu
（Department of Surgry，the General Hospital of Henan Province Yong Coal Group，Yongcheng 476600，Henan Province，China）
关键词:
桥本甲状腺炎; 甲状腺功能低下; 骨化三醇; 低维生素D血症; 自身抗体
Keywords:
Hashimoto′s thyroiditis; hypothyroidism; calcitriol; thyroid hormone; autoantibody
分类号:
R581.4
DOI:
10.7683/xxyxyxb.2017.08.012
文献标志码:
A
摘要:
目的　探讨常规替代治疗基础上联合使用骨化三醇胶丸对桥本甲状腺炎（HT）伴甲状腺功能减退患者甲状腺激素及自身抗体的影响。方法　选择2014年1月至2015年12月河南省永煤集团总医院收治的128例HT伴甲状腺功能减退患者，根据患者治疗意愿分为观察组（65例）和对照组（63例），并选择同期60例健康体检者为正常组。正常组受试者不予治疗，对照组患者口服左旋甲状腺素片，观察组患者在对照组治疗基础上加用骨化三醇胶丸，疗程均为16周；检测观察组、对照组患者治疗前后和正常组受试者血清促甲状腺激素（TSH）、游离三碘甲状腺原氨酸（FT3）、游离甲状腺素（FT4）、抗甲状腺过氧化物酶抗体（TPOAb），同时检测抗甲状腺球蛋白抗体（TGAb）和1,25-羟维生素D3［1，25-（OH）2D3］水平，并对检测结果进行比较。结果　治疗前，观察组、对照组患者血清 FT3、FT4、TSH、TPOAb、TGAb和1，25-（OH）D3比较差异均无统计学意义（P>0.05）；观察组、对照组患者血清FT3、FT4、1，25-（OH）2D3均显著低于正常组，TSH、TPOAb、TGAb均显著高于正常组（P<0.05）。治疗16周后，观察组、对照组患者FT3、FT4、1，25-（OH）2D3均较治疗前显著升高，TSH、TPOAb、TGAb均较治疗前显著下降（P<0.05）；观察组患者治疗后FT3、FT4、1，25-（OH）2D3显著高于对照组，TSH、TPOAb、TGAb显著低于对照组（P<0.05）；与正常组比较，观察组和对照组治疗后FT3、FT4、1，25-（OH）2D3均达到正常组水平，差异均无统计学意义（P>0.05），但TSH、TPOAb、TGAb指标仍高于正常组（P<0.05）。结论　HT合并甲状腺功能减退患者普遍存在低维生素D血症；替代治疗基础上加服骨化三醇胶丸有助于改善低维生素D血症，提高甲状腺激素水平，降低甲状腺自身抗体水平。
Abstract:
Objective　To explore the effect of regular replacement therapy combined with calcitriol capsule on the thyroid hormone and autoantibodies of Hashimoto′s thyroiditis （HT） patients with hypothyroidism.Methods　One hundred and twenty HT patients with hypothyroidism in General Hospital of Henan Yong Coal Group from January 2014 to December 2015 were selected and divided into observation group （n=65） and control group （n=63） according to the treatment willingness of the patients.At the same period，60 healthy subjects were selected as normal group.The subjects in normal group did not give intervention；the patients in control group were given L-thyroxine orally；the patients in observation group were given L-thyroxine and calcitriol capsule；the course of treatment was 16 weeks.The serum thyroid stimulating hormone （TSH），three free iodine thyroid former glycine （FT3），free thyroxine （FT4），resistance to thyroid peroxidase antibody （TPOAb），anti thyroglobulin antibody （TGAb） and 1，25-（OH）2D3 levels of patients in the observation group and control group before and after treatment and subjects in the normal goup were detected.Results　Before treatment，there was no statistic difference in the serum levels of FT3，FT4，TSH，TPOAb，TGAb and 1，25-（OH）2D3 between the observation group and control group （P>0.05）.The serum levels of FT3，FT4，1，25-（OH）2D3 of patients in the observation group and control group were significantly lower than those in the normal group；but the TSH，TPOAb，TGAb levels were significantly higher than those in the normal group （P<0.05）.After 16 weeks treatment，the FT3，FT4，1，25-（OH）2D3 levels of patients in the observation group and control group were significantly higher than those before treatment；the TSH，TPOAb，TGAb levels were significantly lower than those before treatment （P<0.05）；there was no statistic difference in the FT3，FT4，1，25-（OH）2D3 levels of patients between observation group，control group and normal group （P>0.05）；the TSH，TPOAb，TGAb level of patients in the observation group and control group were significantly higher than those in the normal group （P<0.05）.Conclusion　Hypovitaminosis D is common in HT patients with hypothyroidism.The replacement therapy combined with calcitriol capsule can improve hypovitaminosis D，improve the level of thyroid hormone，and decrease the thyroid autoantibodies.

参考文献/References:

［1］　BOZKURT N C，KARBEK B，UCAN B，et al.The association between severity of vitamin D deficiency and Hashimoto′s thyroiditis［J］.Endocr Pract，2013，19（3）：479-484.
［2］　CLINCKSPOOR I，GéRARD A C，VAN SANDE J，et al.The vitamin d receptor in thyroid development and function［J］.Eur Thyroid J，2012，1（3）：168-175.
［3］　中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南［J］.中华内科杂志，2008，47（9）：784-788.
［4］　贺亮，程维刚.甲状腺再次手术特点及并发症分析［J］.新乡医学院学报，2016，33（1）：64-66.
［5］　郭艳风，韩芳毅，周红艳，等.L型氨基酸转运体1和血管内皮生长因子在甲状腺乳头状癌中的表达及意义［J］.新乡医学院学报，2017，34（1）：89-90.
［6］　刘婧茹，王清.夏枯草胶囊对桥本甲状腺炎患者自身抗体及Thl7细胞的影响［J］.中国老年学杂志，2016，32（24）：5413-5415.
［7］　STEFANI C＇ M，PAPI C＇ S，SUVER M.Association of vitamin D receptor gene 3′-variants with Hashimoto′s thyroiditis in the Croatian population［J］.Int J Immunogenet，2016，35（2）：125-131.
［8］　TAMER G，ARIK S，TAMER I，et al.Relative vitamin D insufficiency in Hashimoto′s thyroiditis［J］.Thyroid，2016，21（8）：891-896.
［9］　MANSOURNIA N，MANSOURNIA M A，SAEEDI S，et al.The association between serum 25-（OH）D3 levels and hypothyroid Hashimoto′s thyroiditis［J］.J Endocrinol Invest，2015，37（5）：473-476.
［10］　CLINCKSPOOR I，GRARD A C，VAN SANDE J，et al.The vitamin d receptor in thyroid development and function［J］.Eur Thyroid J，2016，1（3）：168-175.
［11］　FERREIRA G B，OVERBERGH L，VERSTUYF A，et al.1α，25-dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells：a comparison dose-titration study［J］.J Steroid Biochem Mol Biol，2015，136：160-165.
［12］　COUSSENS A K，WILKINSON R J，HANIFA Y，et al.Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment［J］.Proc Natl Acad Sci USA，2016，109（38）：15449-15454.
［13］　CHEN S，SIMS G P，CHEN X X，et al.Modulatory effects of 1，25-dihydroxyvitamin D3 on human B cell differentiation［J］.J Immunol，2016，179（3）：1634-1647.

相似文献/References:

[1]冯　冰.高频超声在桥本甲状腺炎与甲状腺功能亢进症鉴别诊断中的价值[J].新乡医学院学报,2019,36(2):165.[doi:10.7683/xxyxyxb.2019.02.016]
　FENG Bing.Value of high-frequency ultrasound in differential diagnosis of Hashimoto′s thyroiditis and hyperthyroidism[J].Journal of Xinxiang Medical University,2019,36(8):165.[doi:10.7683/xxyxyxb.2019.02.016]
[2]张国玉,万会娜,郭盼盼,等.桥本甲状腺炎发病因素及发病机制研究进展[J].新乡医学院学报,2020,37(10):984.[doi:10.7683/xxyxyxb.2020.10.019]

更新日期/Last Update: 2017-08-05